Experimental Drug Raises Good Cholesterol Levels in Early Trial

(4 stars)
Better than CNN’s story on this same study, HealthDay clearly framed the story around the safety concerns about this new class of drugs that are designed to alter how the body manages cholesterol and avoided promoting premature conclusions about potential health benefits.